TI
RCUS icon

Trexquant Investment’s Arcus Biosciences RCUS Stock Holding History

Trexquant Investment’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Buy
+32,987
New +$815K 0.01% 1456
2025
Q4 		– Sell
-47,593
Closed -$647K – 1872
2025
Q3 		$647K Sell
47,593
-211,344
-82% -$2.2M 0.01% 1261
2025
Q2 		$2.11M Buy
258,937
+43,571
+20% +$372K 0.02% 872
2025
Q1 		$1.69M Sell
215,366
-85,182
-28% -$988K 0.02% 919
2024
Q4 		$4.48M Buy
300,548
+212,552
+242% +$3.47M 0.05% 562
2024
Q3 		$1.35M Sell
87,996
-164,590
-65% -$2.6M 0.02% 945
2024
Q2 		$3.85M Buy
252,586
+214,469
+563% +$3.46M 0.06% 489
2024
Q1 		$720K Sell
38,117
-5,420
-12% -$93.7K 0.01% 1039
2023
Q4 		$832K Sell
43,537
-35,100
-45% -$561K 0.02% 889
2023
Q3 		$1.41M Buy
+78,637
New +$1.58M 0.04% 617
2023
Q2 		– Sell
-18,827
Closed -$343K – 1740
2023
Q1 		$343K Sell
18,827
-6,244
-25% -$119K 0.01% 1145
2022
Q4 		$518K Buy
+25,071
New +$690K 0.01% 902
2022
Q3 		– Sell
-8,190
Closed -$208K – 1767
2022
Q2 		$208K Buy
+8,190
New +$201K 0.01% 1334
2021
Q2 		– Sell
-7,189
Closed -$202K – 1436
2021
Q1 		$202K Sell
7,189
-6,236
-46% -$217K 0.02% 963
2020
Q4 		$349K Sell
13,425
-39,251
-75% -$950K 0.04% 606
2020
Q3 		$903K Buy
52,676
+23,327
+79% +$521K 0.06% 454
2020
Q2 		$726K Buy
29,349
+3,040
+12% +$82K 0.05% 524
2020
Q1 		$365K Buy
+26,309
New +$327K 0.03% 778
2019
Q2 		– Sell
-16,361
Closed -$204K – 1066
2019
Q1 		$204K Buy
+16,361
New +$178K 0.01% 864

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Trexquant Investment's RCUS Position: Q2 2026 in Review

Trexquant Investment opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 32,987 shares worth $1.02M. The stake represents 0.01% of the portfolio and ranks #1456 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in RCUS as recently as Q3 2025.

Trexquant Investment first reported a position in RCUS in Q1 2019 and has held it in 19 quarters since. The position peaked at $4.48M in Q4 2024. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Trexquant Investment held 32,987 shares of Arcus Biosciences worth $1.02M as of Q2 2026.
  • Arcus Biosciences was a new Trexquant Investment position in Q2 2026.
  • Arcus Biosciences made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1456 holding.
  • Trexquant Investment first reported a position in Arcus Biosciences in Q1 2019 and has held it in 19 quarters since.
  • Trexquant Investment's Arcus Biosciences position peaked at $4.48M in Q4 2024.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.